Title: Heterogeneity of Metaplastic Carcinoma of Breast - A Diagnostic Challenge

Authors: Dr Pranita Mohanty, Dr Debahuti Mohapatra, Dr Rohini Choudhuri

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i2.26

Abstract

Background: Metaplastic carcinoma of breast (MCB) is a rare and aggressive type of invasive breast cancer. As it encompasses a variety of distinct histopathologic designations, diagnostic challenges abound. Here, we have documented the incidence of MCB in our tertiary care hospital for a period of 2 year.

Materials and Methods: This prospective study was carried out in the department of histopathology for a period of 2 years (Sep 2015 to Aug 2017). All the previously diagnosed breast carcinoma cases by FNAC and trucut were included in this study. All these patients were operated in the department of General surgery/ Oncosurgery of our institute.  Followed by, the biopsy samples which were analyzed with routine histopathology and immunohistochemistry. With extensive squamous/malignant spindle cell differentiation, increased matrix production and unusually papillaroid patterns, we have diagnosed metaplastic carcinoma.

Results: There were 921 cases of invasive ductal carcinoma of breast (IDC) studied for a period of 2 years. Among them 8 cases were diagnosed as different types of metaplastic carcinoma. Out of which 5 cases showed extensive squamous differentiation, 1 case showed extensive squamous differentiation with papillaroid patterns, 1 case of MCB with spindle cell component & 1 case of matrix producing carcinoma.

Conclusion: MCB merits presentation because of its rarity and difficulty to diagnose, especially if the tumor is composed of areas showing papillaroid pattern or showing direct transition of carcinomatous component to spindle cell,cartilagenous or osseous matrix. Histomorphology and immunohistochemistry is the mainstay for diagnosis of MCB. It is of significant concern because of its prognosis and treatment which is poor in comparison to classical IDC of breast.

Keywords: Invasive breast cancer, papillaroid, squamous differentions, Histomorphology and immunohistochemistry.

References

  1. Reis-Filho JS, Lakhani SR, Gobbi H, Sneige N. Metaplastic carcinomas. In: Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ, eds. WHO Classification of Tumours of the Breast. Lyon, France: IARC Press; 2012:48–52
  2. Pezzi CM, Patel-Pareikh L, Cole K, Franco J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007;14(1):166–173.
  3. Barnes PJ, Boutilier R, Chiasson D, Rayson S. Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat. 2005;91(2):173–178.
  4. Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathological features. J Clin Imaging Sci. 2012;2(1):21.
  5. Oberman HA. Metaplastic carcinoma of the breast: a clinicopathologic study of 29 patients. Am J Surg Pathol. 1987;11(12):918–929.
  6. Lai HW, Tseng LM, Chang TW, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB)—a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013; 22(5):968–973
  7. Shah DR, Tseng WH, Martinez SR. Treatment options for metaplastic breast cancer. ISRN Oncol. 2012;70:61–62.
  8. A. Tavassoli, P. Devilee (Eds.), World Health Organization: Tumors of the Breast and Female Genital Organs, Oxford University, Oxfordshire (2003)
  9. W. Lai, L.M. Tseng, T.W. Chang, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB) – A case controlled comparison study with infiltrating ductal carcinoma Breast, 22 (2013), pp. 968-973
  10. C. Pezzi, P.P. Lina, C. Karin, et al. Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base Ann Surg Oncol, 14 (2007), pp. 166-173
  11. Zhang, F. Lv, Y. Yang, et al. Clinicopathological features and prognosis of metaplastic breast carcinoma: Experie-nce of a major Chinese cancer center Plos One, 10 (6) (2015), p. e0131409, 10.1371/ journal.pone.0131409 e Collection 2015
  12. Linell F, Ljungberg O, Andersson J. Breast carcinoma: aspects of early stages, progression and related problems. Acta Pathol Microbiol Scand Suppl. 1980;(272):1–233
  13. Lee AH. Recent developments in the histological diagnosis of spindle cell carcinomas, fibromatosis and phyllodes tumor of the breast. Histopathology. 2008;52(1):45–57.

Corresponding Author

Dr Pranita Mohanty

Associate Professor, Department of Pathology, IMS & SUM Hospital,

S ‘O’A Deemed to be University, Bhubaneswar, Odisha India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.